Trials / Recruiting
RecruitingNCT06879834
Assessing of Artificial Intelligence-based Software Platform for Diabetic Retinopathy Screening
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 200 (estimated)
- Sponsor
- The Filatov Institute of Eye Diseases and Tissue Therapy · Academic / Other
- Sex
- All
- Age
- 18 Years – 90 Years
- Healthy volunteers
- Accepted
Summary
To examine the potential for the detection of diabetic retinopathy (DR) using the artificial intelligence (AI)-based software platform Retina-AI.
Detailed description
Operator took fundus images with a non-mydriatic fundus camera as per the Retina-AI CheckEye imaging protocol (an optic disc centered image and a fovea centered image for each eye).Thereafter, operator uploaded fundus images in the AI system for processing by the neural network.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | taking fundus photos using non-mydriatic fundus camera | using artificial intelligence to identify diabetic retinopathy in the early stages using fundus photography. |
Timeline
- Start date
- 2024-11-02
- Primary completion
- 2025-08-01
- Completion
- 2025-12-01
- First posted
- 2025-03-17
- Last updated
- 2025-03-17
Locations
1 site across 1 country: Ukraine
Source: ClinicalTrials.gov record NCT06879834. Inclusion in this directory is not an endorsement.